National Bank Of Canada Royalty Pharma PLC Transaction History

National Bank Of Canada

$72.7 Billion
Q3 2024

A detailed history of National Bank Of Canada transactions in Royalty Pharma PLC stock. As of the latest transaction made, National Bank Of Canada holds 1,703 shares of RPRX stock, worth $41,348. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,703

Previous 1,703 -0.0%

Holding current value

$41,348

Previous $48,000 -0.0%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$25.63 - $29.27 $1,999 - $2,283	78 Added 4.8%	1,703 $48,000
Q2 2024 Aug 02, 2024	BUY	$26.26 - $29.9 $2,284 - $2,601	87 Added 5.66%	1,625 $42,000
Q1 2024 May 13, 2024	SELL	$27.46 - $31.33 $915,351 - $1.04 Million	-33,334 Reduced 95.59%	1,538 $46,000
Q4 2023 Feb 06, 2024	SELL	$26.21 - $29.22 $2.08 Million - $2.32 Million	-79,441 Reduced 69.49%	34,872 $979,000
Q3 2023 Oct 10, 2023	BUY	$26.26 - $31.38 $414,960 - $495,866	15,802 Added 16.04%	114,313 $3.1 Million
Q2 2023 Jul 26, 2023	SELL	$29.6 - $36.56 $233,840 - $288,824	-7,900 Reduced 7.42%	98,511 $3.03 Million
Q1 2023 Apr 12, 2023	BUY	$32.77 - $39.4 $2.25 Million - $2.71 Million	68,765 Added 182.66%	106,411 $3.83 Million
Q4 2022 Jan 24, 2023	SELL	$39.17 - $44.04 $2.33 Million - $2.62 Million	-59,433 Reduced 61.22%	37,646 $0
Q3 2022 Oct 13, 2022	BUY	$39.88 - $44.65 $2.88 Million - $3.22 Million	72,144 Added 289.33%	97,079 $3.9 Million
Q2 2022 Jul 28, 2022	SELL	$37.53 - $44.22 $384,644 - $453,210	-10,249 Reduced 29.13%	24,935 $1.07 Million
Q1 2022 May 05, 2022	BUY	$37.46 - $42.44 $471,583 - $534,277	12,589 Added 55.72%	35,184 $1.55 Million
Q4 2021 Jan 24, 2022	BUY	$35.17 - $42.48 $794,666 - $959,835	22,595 New	22,595 $885,000

Others Institutions Holding RPRX

# of Institutions

413

Shares Held

283M

Call Options Held

578K

Put Options Held

47.5K

View Full List

About Royalty Pharma plc

Ticker RPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 437,139,008
Market Cap $10.6B
Description
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...

More about RPRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of National Bank Of Canada , based on Form 13F filings with the SEC.

News

Stay updated on National Bank Of Canada with notifications on news.

Account

National Bank Of Canada Royalty Pharma PLC Transaction History